Privia Health Group, Inc. Stock-Based Compensation
Privia Health Group, Inc. (PRVA) reported Stock-Based Compensation of $41.32 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-06
- Privia Health Group, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $19.40M, a 2.90% increase year-over-year.
- Privia Health Group, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $21.92M, a 23.22% increase year-over-year.
- Privia Health Group, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $15.45M, a 1.13% increase year-over-year.
- Privia Health Group, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $18.98M, a 25.63% increase year-over-year.
- Privia Health Group, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $71.07M, a 25.38% increase from fiscal 2024.
- Privia Health Group, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $56.68M, a 52.78% increase from fiscal 2023.
- Privia Health Group, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $37.10M, a 44.92% decline from fiscal 2022.
- Privia Health Group, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $67.36M, a 73.43% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $19.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $41.32M 10-Q · filed 2026-08-06 | $56.77M derived: sum of 3 quarters · filed 2026-08-06 | $75.75M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $21.92M 10-Q · filed 2026-05-07 | $37.37M derived: sum of 2 quarters · filed 2026-05-07 | $56.35M derived: sum of 3 quarters · filed 2026-05-07 | $75.20M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $15.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $34.43M derived: sum of 2 quarters · filed 2026-02-27 | $53.28M derived: sum of 3 quarters · filed 2026-08-06 | $71.07M 10-K · filed 2026-02-27 |
| 2025-09-30 | $18.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $37.83M derived: sum of 2 quarters · filed 2026-08-06 | $55.62M 10-Q · filed 2025-11-06 | $70.89M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $18.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $36.64M 10-Q · filed 2026-08-06 | $51.92M derived: sum of 3 quarters · filed 2026-08-06 | $67.02M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $17.79M 10-Q · filed 2026-05-07 | $33.07M derived: sum of 2 quarters · filed 2026-05-07 | $48.17M derived: sum of 3 quarters · filed 2026-05-07 | $62.57M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $15.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $30.39M derived: sum of 2 quarters · filed 2026-02-27 | $44.78M derived: sum of 3 quarters · filed 2026-02-27 | $56.68M 10-K · filed 2026-02-27 |
| 2024-09-30 | $15.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $29.50M derived: sum of 2 quarters · filed 2025-11-06 | $41.40M 10-Q · filed 2025-11-06 | $53.07M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $14.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $26.30M 10-Q · filed 2025-08-07 | $37.96M derived: sum of 3 quarters · filed 2026-02-27 | $48.77M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $11.90M 10-Q · filed 2025-05-08 | $23.57M derived: sum of 2 quarters · filed 2026-02-27 | $34.37M derived: sum of 3 quarters · filed 2026-02-27 | $43.62M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $11.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $22.47M derived: sum of 2 quarters · filed 2026-02-27 | $31.72M derived: sum of 3 quarters · filed 2026-02-27 | $37.10M 10-K · filed 2026-02-27 |
| 2023-09-30 | $10.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $20.05M derived: sum of 2 quarters · filed 2024-11-07 | $25.43M 10-Q · filed 2024-11-07 | $34.60M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $9.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $14.63M 10-Q · filed 2024-08-08 | $23.80M derived: sum of 3 quarters · filed 2025-02-27 | $38.64M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $5.38M 10-Q · filed 2024-05-09 | $14.56M derived: sum of 2 quarters · filed 2025-02-27 | $29.39M derived: sum of 3 quarters · filed 2025-02-27 | $47.86M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $9.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $24.01M derived: sum of 2 quarters · filed 2025-02-27 | $42.48M derived: sum of 3 quarters · filed 2025-02-27 | $67.36M 10-K · filed 2025-02-27 |
| 2022-09-30 | $14.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $33.30M derived: sum of 2 quarters · filed 2023-11-03 | $58.18M 10-Q · filed 2023-11-03 | $83.25M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $18.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $43.35M 10-Q · filed 2023-08-03 | $68.42M derived: sum of 3 quarters · filed 2024-02-27 | $94.22M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $24.88M 10-Q · filed 2023-05-04 | $49.95M derived: sum of 2 quarters · filed 2024-02-27 | $75.75M derived: sum of 3 quarters · filed 2024-02-27 | $278.31M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $25.07M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $50.87M derived: sum of 2 quarters · filed 2024-02-27 | $253.43M derived: sum of 3 quarters · filed 2024-02-27 | $253.53M 10-K · filed 2024-02-27 |
| 2021-09-30 | $25.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $228.36M derived: sum of 2 quarters · filed 2022-11-10 | $228.46M 10-Q · filed 2022-11-10 | $228.58M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $202.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $202.66M 10-Q · filed 2022-08-11 | $202.78M derived: sum of 3 quarters · filed 2023-03-01 | $202.90M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $101.00K 10-Q · filed 2022-05-12 | $222.00K derived: sum of 2 quarters · filed 2023-03-01 | $343.00K derived: sum of 3 quarters · filed 2023-03-01 | $464.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $121.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $242.00K derived: sum of 2 quarters · filed 2023-03-01 | $363.00K derived: sum of 3 quarters · filed 2023-03-01 | $484.00K 10-K · filed 2023-03-01 |
| 2020-09-30 | $121.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $242.00K derived: sum of 2 quarters · filed 2021-11-08 | $363.00K 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $121.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $242.00K 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | $121.00K 10-Q · filed 2021-05-28 | |||
| 2019-12-31 | $207.00K 10-K · filed 2022-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |